China Pharma Stock Price

0.05005 (7.31%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
China Pharma Holdings Inc CPHI AMEX Common Stock
  Price Change Change Percent Stock Price Last Traded
0.05005 7.31% 0.734351 15:33:54
Open Price Low Price High Price Close Price Prev Close
0.69 0.69 0.745 0.6843
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
2,540 1,969,283 $ 0.7117954 $ 1,401,727 1,770,807 0.2988 - 1.45
Last Trade Time Type Quantity Stock Price Currency
15:33:54 5,000 $ 0.734351 USD

China Pharma Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 33.47M 45.58M 26.22M $ 10.92M $ -2.28M -0.49 -1.40
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

China Pharma News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CPHI Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.670.770.61020.71033381,749,3330.064359.6%
1 Month0.44750.8470.43980.64491452,507,4540.2868564.1%
3 Months0.3840.8470.370.5903371,236,3250.3503591.24%
6 Months0.51010.8470.320.5419389872,7190.2242543.96%
1 Year0.3991.450.29880.62659281,866,2430.3353584.05%
3 Years0.3851.450.190.5306991959,2810.3493590.74%
5 Years0.151.450.120.5042476681,0170.58435389.57%

China Pharma Description

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablet, clarithromycin granule, roxithromycin dispersible tablet, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.

Your Recent History
China Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.